Category
104 articles — page 5 of 9
May 14, 2026
Leucoderma and vitiligo are often used interchangeably — especially in South Asian contexts — but they are not exactly the same thing. Here is the precise distinction, and why it matters for diagnosis and treatment.
May 14, 2026
Type 1 diabetes is the third most common comorbidity in vitiligo patients, sharing genetic susceptibility and immune mechanisms. Understanding the link, what to monitor, and how treatment choices interact across both conditions.
May 9, 2026
Focal vitiligo appears as one or a few small patches in a limited area. A long-term follow-up study found 23% of cases progress to generalised vitiligo over 7 years — here is what the data shows about spread risk, progression timing, and treatment options including in children.
May 9, 2026
Depigmented skin has zero melanin defence — it burns faster and tans unevenly. Here is exactly how to protect vitiligo patches, which sunscreen formulas to use, and how phototherapy patients should adjust their routine.
April 13, 2026
Gut health, stress reduction, diet, and supplements in vitiligo — a grounded look at what the research actually supports and where the evidence is genuinely thin.
April 13, 2026
Home narrowband UVB is one of the most effective options available to vitiligo patients — but getting the dose, timing, and safety protocol right matters. This guide covers how to use a home NbUVB device safely and effectively, including starting doses, progression, side effects to watch for, and how to protect sensitive areas.
April 13, 2026
For many patients, stopping vitiligo from spreading is a more urgent goal than repigmentation. Here is what the evidence shows works for stabilization — and what the triggers are that drive active spread.
April 13, 2026
Searching for melanin supplements for vitiligo? Here is what the evidence says about every product category — what might help, what is useless, and what to avoid.
April 13, 2026
Ruxolitinib cream works well on the face but poorly on hands and feet. Here is why acral vitiligo responds differently and what combination strategies actually move the needle.
April 13, 2026
Ruxolitinib cream (Opzelura) combined with narrowband UVB is emerging as the most effective non-surgical approach for vitiligo repigmentation. Here is the evidence behind the combination, the practical protocol, and what you can realistically expect.
April 13, 2026
Vitiligo patients need daily sunscreen, and the guidance changes during pregnancy. Here is which sunscreen ingredients are considered safe in pregnancy, which to avoid, and the practical recommendations for protecting depigmented skin while pregnant.
April 13, 2026
Not all vitiligo patches respond the same way. The face responds well to most treatments. The hands and feet are notoriously resistant. Here is a body-area breakdown of what works where, why location matters, and how to set realistic expectations for each site.
